Susan M. Molineaux, Ph.D.
Nominating and Corporate Governance Committee (Chair)
Susan M. Molineaux, Ph.D., has served as a director of Geron since September 2012.
Dr. Molineaux has been Chief Executive Officer, President and a member of the board of directors of Calithera Biosciences, Inc. since co-founding the company in June 2010. She also serves as a member of the board of directors of Theravance Biopharma, Inc. since April 2015, where she is a member of the Sciences and Technology Committee, and as a Scientific Advisor to Lightstone Ventures since September 2016. Prior to Calithera, Dr. Molineaux co-founded Proteolix, Inc., where she served as Chief Scientific Officer from December 2003 until December 2005 and from February 2009 until November 2009, and as President and Chief Executive Officer from January 2006 until February 2009, until the company’s acquisition by Onyx Pharmaceuticals, Inc. in November 2009.
Previously, Dr. Molineaux held several senior management positions in the biopharmaceutical industry, including Vice President of Biology at Rigel Pharmaceuticals, Inc.; Vice President of Biology at Praelux, Inc.; and Vice President of Drug Development at Praecis Pharmaceuticals, Inc. Dr. Molineaux holds a B.S. in biology from Smith College, a Ph.D. in molecular biology from Johns Hopkins University, and completed a postdoctoral fellowship at Columbia University.